Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Over the Counter (OTC) Drugs & Dietary Supplements Market by Type (Vitamin and Dietary Supplements, Cough & Cold Products, Analgesics, Gastrointestinal Products, Sleep Aids, Otic Products, Wart Removers, Mouth Care Products, Ophthalmic Products, Other), By Application (Pharmacies, Grocery Stores, Vitamin, Health Food Stores, Online Pharmacies) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Over the Counter (OTC) Drugs & Dietary Supplements Market by Type (Vitamin and Dietary Supplements, Cough & Cold Products, Analgesics, Gastrointestinal Products, Sleep Aids, Otic Products, Wart Removers, Mouth Care Products, Ophthalmic Products, Other), By Application (Pharmacies, Grocery Stores, Vitamin, Health Food Stores, Online Pharmacies) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 205145 3300 Pharma & Healthcare 377 243 Pages 4.6 (38)
                                          

Industry Growth Insights published a new data on “Over the Counter (OTC) Drugs & Dietary Supplements Market”. The research report is titled “Over the Counter (OTC) Drugs & Dietary Supplements Market research by Types (Vitamin and Dietary Supplements, Cough & Cold Products, Analgesics, Gastrointestinal Products, Sleep Aids, Otic Products, Wart Removers, Mouth Care Products, Ophthalmic Products, Other), By Applications (Pharmacies, Grocery Stores, Vitamin, Health Food Stores, Online Pharmacies), By Players/Companies Pfizer Inc., Novartis International AG, Roche Holding AG, Merck & Co., Inc., Sanofi S.A, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline plc., Bayer Healthcare AG, AstraZeneca plc., Alacer Corp., Alcon Inc., Alfresa Pharma Corporation, Alkalon A/S, Alliance Healthcare, Allergan, Plc., Reckitt Benckiser Plc., Bausch & Lomb, AbbVie Inc., The Colgate-Palmolive Company”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Over the Counter (OTC) Drugs & Dietary Supplements Market Research Report

By Type

Vitamin and Dietary Supplements, Cough & Cold Products, Analgesics, Gastrointestinal Products, Sleep Aids, Otic Products, Wart Removers, Mouth Care Products, Ophthalmic Products, Other

By Application

Pharmacies, Grocery Stores, Vitamin, Health Food Stores, Online Pharmacies

By Companies

Pfizer Inc., Novartis International AG, Roche Holding AG, Merck & Co., Inc., Sanofi S.A, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline plc., Bayer Healthcare AG, AstraZeneca plc., Alacer Corp., Alcon Inc., Alfresa Pharma Corporation, Alkalon A/S, Alliance Healthcare, Allergan, Plc., Reckitt Benckiser Plc., Bausch & Lomb, AbbVie Inc., The Colgate-Palmolive Company

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

243

Number of Tables & Figures

171

Customization Available

Yes, the report can be customized as per your need.


Global Over the Counter (OTC) Drugs & Dietary Supplements Industry Outlook


Global Over the Counter (OTC) Drugs & Dietary Supplements Market Report Segments:

The global Over the Counter (OTC) Drugs & Dietary Supplements market is segmented on the basis of:

Types

Vitamin and Dietary Supplements, Cough & Cold Products, Analgesics, Gastrointestinal Products, Sleep Aids, Otic Products, Wart Removers, Mouth Care Products, Ophthalmic Products, Other

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Pharmacies, Grocery Stores, Vitamin, Health Food Stores, Online Pharmacies

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Pfizer Inc.
  2. Novartis International AG
  3. Roche Holding AG
  4. Merck & Co., Inc.
  5. Sanofi S.A
  6. Johnson & Johnson
  7. Gilead Sciences
  8. GlaxoSmithKline plc.
  9. Bayer Healthcare AG
  10. AstraZeneca plc.
  11. Alacer Corp.
  12. Alcon Inc.
  13. Alfresa Pharma Corporation
  14. Alkalon A/S
  15. Alliance Healthcare
  16. Allergan, Plc.
  17. Reckitt Benckiser Plc.
  18. Bausch & Lomb
  19. AbbVie Inc.
  20. The Colgate-Palmolive Company

Global Over the Counter (OTC) Drugs & Dietary Supplements Market Overview


Highlights of The Over the Counter (OTC) Drugs & Dietary Supplements Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Vitamin and Dietary Supplements
    2. Cough & Cold Products
    3. Analgesics
    4. Gastrointestinal Products
    5. Sleep Aids
    6. Otic Products
    7. Wart Removers
    8. Mouth Care Products
    9. Ophthalmic Products
    10. Other
  1. By Application:

    1. Pharmacies
    2. Grocery Stores
    3. Vitamin
    4. Health Food Stores
    5. Online Pharmacies
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Over the Counter (OTC) Drugs & Dietary Supplements Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Over the Counter (OTC) Drugs & Dietary Supplements Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Over the counter (OTC) drugs and dietary supplements are products that are not typically prescribed by a doctor, but can be purchased without a prescription from most pharmacies. OTC drugs include medications such as ibuprofen, acetaminophen, and aspirin; vitamins such as vitamin C and E; minerals such as magnesium and potassium; herbal supplements; and diet pills. Dietary supplements include items like multivitamins, minerals, herbs, amino acids, weight-loss products, energy drinks/shots/sports drinks etc.

Some of the major companies in the over the counter (otc) drugs & dietary supplements market are Pfizer Inc., Novartis International AG, Roche Holding AG, Merck & Co., Inc., Sanofi S.A, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline plc., Bayer Healthcare AG, AstraZeneca plc., Alacer Corp., Alcon Inc., Alfresa Pharma Corporation, Alkalon A/S, Alliance Healthcare, Allergan, Plc., Reckitt Benckiser Plc., Bausch & Lomb, AbbVie Inc., The Colgate-Palmolive Company.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Over the Counter (OTC) Drugs & Dietary Supplements Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Over the Counter (OTC) Drugs & Dietary Supplements Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Over the Counter (OTC) Drugs & Dietary Supplements Market - Supply Chain
   4.5. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Forecast
      4.5.1. Over the Counter (OTC) Drugs & Dietary Supplements Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Over the Counter (OTC) Drugs & Dietary Supplements Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Over the Counter (OTC) Drugs & Dietary Supplements Market Absolute $ Opportunity

5. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Volume Forecast by Type
      5.3.1. Vitamin and Dietary Supplements
      5.3.2. Cough & Cold Products
      5.3.3. Analgesics
      5.3.4. Gastrointestinal Products
      5.3.5. Sleep Aids
      5.3.6. Otic Products
      5.3.7. Wart Removers
      5.3.8. Mouth Care Products
      5.3.9. Ophthalmic Products
      5.3.10.   Other
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Volume Forecast by Application
      6.3.1. Pharmacies
      6.3.2. Grocery Stores
      6.3.3. Vitamin
      6.3.4. Health Food Stores
      6.3.5. Online Pharmacies
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Over the Counter (OTC) Drugs & Dietary Supplements Demand Share Forecast, 2019-2026

9. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Volume Forecast by Application
      9.4.1. Pharmacies
      9.4.2. Grocery Stores
      9.4.3. Vitamin
      9.4.4. Health Food Stores
      9.4.5. Online Pharmacies
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Volume Forecast by Type
      9.7.1. Vitamin and Dietary Supplements
      9.7.2. Cough & Cold Products
      9.7.3. Analgesics
      9.7.4. Gastrointestinal Products
      9.7.5. Sleep Aids
      9.7.6. Otic Products
      9.7.7. Wart Removers
      9.7.8. Mouth Care Products
      9.7.9. Ophthalmic Products
      9.7.10.   Other
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Over the Counter (OTC) Drugs & Dietary Supplements Demand Share Forecast, 2019-2026

10. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Volume Forecast by Application
      10.4.1. Pharmacies
      10.4.2. Grocery Stores
      10.4.3. Vitamin
      10.4.4. Health Food Stores
      10.4.5. Online Pharmacies
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Volume Forecast by Type
      10.7.1. Vitamin and Dietary Supplements
      10.7.2. Cough & Cold Products
      10.7.3. Analgesics
      10.7.4. Gastrointestinal Products
      10.7.5. Sleep Aids
      10.7.6. Otic Products
      10.7.7. Wart Removers
      10.7.8. Mouth Care Products
      10.7.9. Ophthalmic Products
      10.7.10.   Other
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Demand Share Forecast, 2019-2026

11. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Volume Forecast by Application
      11.4.1. Pharmacies
      11.4.2. Grocery Stores
      11.4.3. Vitamin
      11.4.4. Health Food Stores
      11.4.5. Online Pharmacies
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Over the Counter OTC) Drugs & Dietary Supplements Market Size and Volume Forecast by Type
      11.7.1. Vitamin and Dietary Supplements
      11.7.2. Cough & Cold Products
      11.7.3. Analgesics
      11.7.4. Gastrointestinal Products
      11.7.5. Sleep Aids
      11.7.6. Otic Products
      11.7.7. Wart Removers
      11.7.8. Mouth Care Products
      11.7.9. Ophthalmic Products
      11.7.10.   Other
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Over the Counter (OTC) Drugs & Dietary Supplements Demand Share, 2019-2026

12. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Volume Forecast by Application
      12.4.1. Pharmacies
      12.4.2. Grocery Stores
      12.4.3. Vitamin
      12.4.4. Health Food Stores
      12.4.5. Online Pharmacies
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Volume Forecast by Type
      12.7.1. Vitamin and Dietary Supplements
      12.7.2. Cough & Cold Products
      12.7.3. Analgesics
      12.7.4. Gastrointestinal Products
      12.7.5. Sleep Aids
      12.7.6. Otic Products
      12.7.7. Wart Removers
      12.7.8. Mouth Care Products
      12.7.9. Ophthalmic Products
      12.7.10.   Other
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Demand Share, 2019-2026

13. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Volume Forecast by Application
      13.4.1. Pharmacies
      13.4.2. Grocery Stores
      13.4.3. Vitamin
      13.4.4. Health Food Stores
      13.4.5. Online Pharmacies
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Volume Forecast by Type
      13.7.1. Vitamin and Dietary Supplements
      13.7.2. Cough & Cold Products
      13.7.3. Analgesics
      13.7.4. Gastrointestinal Products
      13.7.5. Sleep Aids
      13.7.6. Otic Products
      13.7.7. Wart Removers
      13.7.8. Mouth Care Products
      13.7.9. Ophthalmic Products
      13.7.10.   Other
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Over the Counter (OTC) Drugs & Dietary Supplements Market: Market Share Analysis
   14.2. Over the Counter (OTC) Drugs & Dietary Supplements Distributors and Customers
   14.3. Over the Counter (OTC) Drugs & Dietary Supplements Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Pfizer Inc.
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Novartis International AG
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Roche Holding AG
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Merck & Co., Inc.
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Sanofi S.A
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Johnson & Johnson
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Gilead Sciences
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. GlaxoSmithKline plc.
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Bayer Healthcare AG
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. AstraZeneca plc.
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Alacer Corp.
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Alcon Inc.
       &nb

Our Trusted Clients

Contact Us